// App-Quantinova.ai

PO‐096 : Symptomatic skeletal lesions: a previously unreported manifestation of Waldenström's macroglobulinaemia, which can represent disease progression

Researchers

Presenter

  • A O'Neill

Principal Investigators

  • K Rajesparan

  • C Yeomans

  • S D'Sa

Medical Centers

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Alkaline phosphatase

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bendamustine

  • Cytarabine liposomal

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

  • Rituximab

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved